Accuracy Assessment of Sleep Monitoring Technology
To Evaluate the Accuracy of Sleep Parameters Evaluated by Wearable Sleep Devices
1 other identifier
observational
50
1 country
1
Brief Summary
As a necessary process of life, sleep is an important link for the body to recover, integrate and consolidate memory. However, the fast pace of life in modern society and people's bad living habits are easy to cause sleep disorders. Sleep disorders are often the main factors that induce or aggravate cardiovascular and cerebrovascular diseases. Sleep staging is an important basis for sleep quality assessment and related disease diagnosis. At present, electroencephalography (EEG) has become the gold standard for judging sleep stages. However, this kind of method requires long-term contact of multiple electrodes with the human body, which is easy to affect the natural sleep of the subjects, so it is not suitable for sleep monitoring in home environment. Studies have shown that sleep is related to the regulation of autonomic nervous system, and heart rate variability (HRV) in sleep also shows periodic changes similar to brain waves. Smartwatch/bracelet can continuously monitor the user's pulse wave and acceleration data comfortably and without feeling. HRV features can be extracted using pulse wave data, and then sleep staging can be realized based on the correlation between HRV and brain waves, and sleep quality can be evaluated. Therefore, healthy sleep research aims to use smart devices to achieve sleep monitoring in the home environment and improve people's sleep quality
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Oct 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2022
CompletedFirst Submitted
Initial submission to the registry
October 26, 2022
CompletedFirst Posted
Study publicly available on registry
December 5, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2022
CompletedDecember 5, 2022
November 1, 2022
3 months
October 26, 2022
November 23, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Accuracy of sleep parameters of wearable devices
Sleep Latency,sleep efficiency
8-10AM
Study Arms (1)
smart bracelet
Type and specification:FRA-B39
Interventions
No intervention was done for the subjects
Eligibility Criteria
china
You may qualify if:
- a. Adults aged 18 and above and under the age of 60; The age of the subjects was divided into two age groups: 18-44, 45-60, and the ratio between the two groups was 1:1.2-1:0.8. The ratio of female to male is between 1:1.1 and 1:1.0; b. No patients with serious cardiovascular and cerebrovascular diseases, moderate degree of depression, anxiety disorder or severe apnea; HAMD\<=20;HAMA \<=13;AHI\< 30 c. Subjects did not drink alcohol or take sleep intervention drugs during the program; d. People with sleep disorders and insomnia can be included in the subjects, but the total number is no more than 50%, and should be clearly marked; e. Having Chinese nationality and residing in China; f. Agree to be monitored by PSG and wear wearable devices; Voluntary entry, informed consent or consent to privacy agreement.
You may not qualify if:
- a. Patients with a history of depression, anxiety and other mental disorders; HAMD\>20;HAMA\>13 b. Patients with existing atherosclerotic cardiovascular diseases, such as coronary heart disease and severe peripheral atherosclerotic disease; c. age \>60 d. Patients with obstructive sleep apnea (AHI \>30); Use of drugs or substances affecting the central nervous system in the preceding 2 weeks.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Shanshan Lulead
Study Sites (1)
Shanshan Lu
Jinan, Shandong, 250014, China
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Doctor of Medicine(M.D.)
Study Record Dates
First Submitted
October 26, 2022
First Posted
December 5, 2022
Study Start
October 1, 2022
Primary Completion
December 30, 2022
Study Completion
December 30, 2022
Last Updated
December 5, 2022
Record last verified: 2022-11